Theratechnologies INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Soleus Capital Urges Theratechnologies Board to Engage with Future Pak's Premium Acquisition Offer
Soleus Capital, a significant shareholder in Theratechnologies Inc., has publicly urged the company's Board of Directors to engage with Future Pak's recent acquisition proposal, which offers a substantial premium to current share prices.